Truist Securities maintains Exelixis at Hold, raises price target to $60 from $54

What happened

Truist Securities maintained a Hold rating on Exelixis and raised its price target to $60 from $54, an 11.1% increase. The new target implies a 9.4% downside from the October 29 close of $66.20.

Confirmed

Global impact / market context

A higher price target suggests the analyst sees more value than before, but a Hold rating means they do not recommend buying. The target still sits below the current price, so the stock would need to fall about 9.4% to reach it.

Analyst inference

Recent analyst targets on Exelixis range from $51 to $65 across four notes in 30 days, showing divided views. Truist's target sits in the middle of that range, while the stock trades above all but the highest target.

Analyst inference

What to watch

1. Truist's $60 target is below the October 29 close of $66.20, implying 9.4% downside, so watch whether the share price moves toward that target. Confirmed
2. Watch for any further analyst notes on Exelixis that raise or lower targets, since the recent range of $51 to $65 shows views can shift quickly. Proposed
3. Watch whether other analysts follow Truist in lifting targets, which could signal growing confidence in the company's prospects despite the Hold rating. Analyst inference

Evidence

• Original source link unavailable